2026年

• 1. Chonabayashi K, Iwasaki M, Kanda J, Takamori H, Yoda A, Kawata T, Mizuta S, Sakurada M, Kondo T, Hiramoto N, Ueda Y, Gotoh A, Watanabe M, Kasahara S, Ishikawa Y, Kiyoi H, Imada K, Mitani K, Kitano T, Arima N, Nakabo Y, Sezaki N, Kanemura N, Fukuda T, Ichikawa M, Miyazaki Y, Fuji S, Sakata-Yanagimoto M, Yoshida Y, Takaori-Kondo A, Ogawa S, Nannya Y. NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners. Leukemia 40(3):491-501, Mar, 2026 (doi: 10.1038/s41375-025-02848-4.) Epub Jan 7, 2026
• 2. Kiyoki Y, Maruyama Y, Arai Y, Ogino Y, Suehara Y, Sasaki Y, Hattori K, Sakamoto T, Kato T, Kurita N, Obara N, Chiba S, Sakata-Yanagimoto M, Nishikii H. Tracking of donor erythropoiesis following ABO-incompatible allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther 32(4):431.e1-431.e4, Apr, 2026 (doi: 10.1016/j.jtct.2026.01.003.) Epub Jan 9, 2026
• 3. Yamasaki S, Yanada M, Mizuno S, Shimomura Y, Toubai T, Harada K, Uchida N, Tanaka M, Wake A, Onizuka M, Eto T, Uehara Y, Takahashi S, Izumi T, Doki N, Tokunaga M, Kawakita T, Nishida T, Sakata-Yanagimoto M, Ishimaru F, Kanda J, Atsuta Y, Konuma T. GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study. Blood Adv 10(8):2648-2660, Apr 28, 2026 (doi: 10.1182/bloodadvances.2025018626.) Epub Jan 15, 2026
• 4. Kaieda T, Makishima K, Suma S, Sasaki Y, Suehara Y, Yasuda H, Matsuoka R, Matsumura F, Sakamoto T, Hattori K, Kato T, Nanmoku T, Kurita N, Nishiki H, Sakata-Yanagimoto M. Discordant lymphoma consisting of splenic marginal zone lymphoma and diffuse large B-cell lymphoma in a hepatitis B virus carrier suggests virus-associated lymphomagenesis. J Clin Exp Hematop 66(1):69-74, Mar 31, 2026 (doi: 10.3960/jslrt.25068.) Epub Jan 28, 2026>
• 5. Sakurai M, Ueda Y, Obara N, Kroes M, Dochi T, Wiyani A, Balp MM, Somenzi O, Taylor Y, Kawaguchi T, Nishimura JI. Disease burden and treatment patterns of paroxysmal nocturnal hemoglobinuria in Japan: a real-world survey. Int J Hematol 123(6):837-847, Jun, 2026 (doi: 10.1007/s12185-026-04170-w.) Epub Feb 11, 2026
• 6. Okaya S, Ito H, Shiba T, Kurihara Y, Hattori K, Inoue M, Ma D, Kawano S, Shimojo N. Severe Transfusion-refractory Cytopenia Mimicking Bone Marrow Failure in a Patient Living with HIV after Antiretroviral Therapy Interruption. Intern Med (doi: 10.2169/internalmedicine.7009-25.) Online ahead of print Mar 3, 2026
• 7. Tzioni MM, Watanabe N, Stelloo E, Chen Z, Ghosh A, Wu F, Sugino K, Ito K, Feitsma H, Fujisawa M, Sakata-Yanagimoto M, Rásó-Barnett L, Marafioti T, Attygalle AD, Wotherspoon A, Du MQ. Different primary thyroid B-cell lymphomas show overlapping mutation profiles, suggesting involvement of a common pathogenic process. Haematologica (doi: 10.3324/haematol.2025.288239.) Online ahead of print Mar 19, 2026
• 8. Fuji S, Ohmoto A, Najima Y, Yoshimura K, Uchida N, Tanaka M, Hasegawa Y, Fukuda T, Asada N, Sawa M, Sakata-Yanagimoto M, Ishimura M, Onizuka M, Nishida T, Doki N, Kawamura K, Hino M, Kanda Y, Atsuta Y, Yakushijin K. Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantation. Br J Haematol 208(6):2168-2174, Jun, 2026 (doi: 10.1111/bjh.70450.) Epub Mar 22, 2026
• 9. Imahashi N, Konuma T, Kobayashi S, Watanabe M, Takahashi S, Nishida T, Kawakita T, Nakamae H, Doki N, Onishi Y, Sakata-Yanagimoto M, Kanda Y, Tanaka M, Eto T, Yoshinaga N, Ishimaru F, Ichinohe T, Atsuta Y, Kanda J. Int J Hematol. Are matched-related donors always the best choice? A retrospective study exploring the potential of umbilical cord blood. Int J Hematol (doi: 10.1007/s12185-026-04200-7.) Online ahead of print Apr 2, 2026
• 10. Oda S, Doki K, Obara N, Sakata-Yanagimoto M, Homma M. Eltrombopag-induced clinically negligible negative bias in creatinine measurements using enzymatic assays. Clin Chem Lab Med (doi: 10.1515/cclm-2026-0216.) Online ahead of print Apr 7, 2026
• 11. Arai Y, Ohbiki M, Kurata M, Ota S, Tanaka M, Imada K, Fukuda T, Katayama Y, Doki N, Kanda Y, Sakata-Yanagimoto M, Onodera K, Hiramoto N, Asada N, Ishida T, Uchida H, Uno S, Teshima T, Takami A, Konuma T, Yanada M, Atsuta Y, Yano S. Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemia. Transplant Cell Ther :S2666-6367(26)00259-9. (doi: 10.1016/j.jtct.2026.03.042.) Online ahead of print Apr 11, 2026
• 12. Nakaya Y, Nakamae H, Sugita J, Kanda J, Hasegawa Y, Eto T, Fukuda T, Kurita N, Hiramoto N, Nagafuji K, Ota S, Asada N, Ando T, Kawakita T, Akasaka T, Mori Y, Kamimura T, Onizuka M, Atsuta Y, Nakasone H. HLA-matched versus haploidentical donor transplantation with post-transplant cyclophosphamide: a study on behalf of the donor/source working group of the Japanese society for transplantation and cellular therapy. Ann Hematol 105(5):255, Apr 20, 2026 (doi: 10.1007/s00277-026-07014-z.)
• 13. Oda S, Doki K, Obara N, Suzuki Y, Sakata-Yanagimoto M, Homma M. Concentration dependency of an acyl glucuronide metabolite in eltrombopag-induced hepatotoxicity: Role of UGT1A1 genotype. Br J Clin Pharmacol (doi: 10.1002/bcp.70585.) Online ahead of print Apr 28, 2026
• 14. Takahashi-Kobayashi M, Nishikii H, Shimizu T, Kaneko Y, Sakata-Yanagimoto M, Usui J. JAK Inhibitor-Induced Improvement of IgA Nephropathy in a Patient With Polycythemia Vera: A Case Report. Kidney Med 8(7):101376, eCollection, Jul, 2026 (doi: 10.1016/j.xkme.2026.101376.) Epub Apr 27, 2026
• 15. Yanagisawa R, Kato I, Hayashi H, Fujiwara SI, Doki N, Hasegawa Y, Kako S, Shibasaki Y, Yoshihara S, Hiramoto N, Fukuda T, Uchida N, Nakamae H, Eto T, Nagafuji K, Sakata-Yanagimoto M, Tanaka M, Umeda K, Kanda Y, Tabuchi K, Atsuta Y, Kanda J, Nakasone H. Comparative outcomes of umbilical cord blood transplantation versus haploidentical transplantation according to post-transplant cyclophosphamide use in adolescent and young adult patients. Bone Marrow Transplant (doi: 10.1038/s41409-026-02916-y.) Online ahead of print May 29, 2026
• 16. Itagaki M, Kuwazawa H, Sasaki S, Matsuura M, Tanaka Y, Obara N. Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in Japan. Ann Hematol (doi: 10.1007/s00277-026-07062-5.) Online ahead of print May 30, 2026